Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             43 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Adherence to postoperative thromboprophylactic medication among gynecologic oncology patients: A subanalysis Ross, Megan E.

158 3 p. 754-759
artikel
2 A guide to establishing a hyperthermic intraperitoneal chemotherapy program in gynecologic oncology Chambers, Laura M.

158 3 p. 794-802
artikel
3 A multimodality triage algorithm to improve cytoreductive outcomes in patients undergoing primary debulking surgery for advanced ovarian cancer: A Memorial Sloan Kettering Cancer Center team ovary initiative Straubhar, Alli M.

158 3 p. 608-613
artikel
4 A multivariate analysis of the prognostic impact of tumor burden, surgical timing and complexity after complete cytoreduction for advanced ovarian cancer Angeles, Martina Aida

158 3 p. 614-621
artikel
5 Bowel resection or repair at the time of cytoreductive surgery for ovarian malignancy is associated with increased complication rate: An ACS-NSQIP study Bernard, Laurence

158 3 p. 597-602
artikel
6 Corrigendum to ‘Identification of a RNA-seq-based signature to improve prognostics for uterine sarcoma’ [Gynecologic Oncology 155 (2019) 499–507] Zhou, Jian-Guo

158 3 p. 812
artikel
7 Derangements in HUWE1/c-MYC pathway confer sensitivity to the BET bromodomain inhibitor GS-626510 in uterine cervical carcinoma Bonazzoli, Elena

158 3 p. 769-775
artikel
8 Diagnostic value of frozen section examination of sentinel lymph nodes in early-stage cervical cancer at the time of ultrastaging Balaya, V.

158 3 p. 576-583
artikel
9 Does timing of intraperitoneal chemotherapy initiation following primary cytoreductive surgery with bowel resection impact outcomes in patients with advanced ovarian cancer? Nica, Andra

158 3 p. 622-630
artikel
10 Editorial board
158 3 p. xii
artikel
11 Feasibility of tumor testing for BRCA status in high-grade serous ovarian cancer using fresh-frozen tissue based approach Marchetti, Claudia

158 3 p. 740-746
artikel
12 Following chemotherapy for gestational trophoblastic neoplasia, do residual lung lesions increase the risk of relapse? Bouchard-Fortier, Genevieve

158 3 p. 698-701
artikel
13 Frailty is a determinant of suboptimal chemotherapy in women with advanced ovarian cancer Narasimhulu, Deepa Maheswari

158 3 p. 646-652
artikel
14 Genomic characterization of vulvar squamous cell carcinoma Prieske, Katharina

158 3 p. 547-554
artikel
15 Historical and projected hysterectomy rates in the USA: Implications for future observed cervical cancer rates and evaluating prevention interventions Simms, Kate T.

158 3 p. 710-718
artikel
16 Immune checkpoint inhibitors in women with gynecologic cancers: Practical considerations Kurnit, Katherine C.

158 3 p. 531-537
artikel
17 Indications and practice of diverting ileostomy after colorectal resection and anastomosis in ovarian cancer cytoreduction Lago, V.

158 3 p. 603-607
artikel
18 Insomnia and its association with quality of life in women with ovarian cancer Ross, Tanya L.

158 3 p. 760-768
artikel
19 Long term follow-up of a large series of stage-II/III atypical proliferative serous ovarian tumors Maria, Sophie

158 3 p. 659-665
artikel
20 Long-term survival in obese patients after robotic or open surgery for endometrial cancer Lindfors, Anna

158 3 p. 673-680
artikel
21 Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival Brieger, Katharine K.

158 3 p. 702-709
artikel
22 Molecular characterization of vulvar squamous cell cancer: High time to gain ground Zeimet, Alain G.

158 3 p. 519-520
artikel
23 Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG network Derquin, F.

158 3 p. 666-672
artikel
24 Nomograms based on the novel platelet index score predict postoperative prognosis in endometrial cancer Chen, Hao

158 3 p. 689-697
artikel
25 Perioperative outcomes of women with and without class III obesity undergoing hysterectomy for endometrioid endometrial cancer: A population-based study Simpson, A.N.

158 3 p. 681-688
artikel
26 Phase 1b study of anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) in patients with platinum-sensitive recurrent ovarian cancer Moore, Kathleen N.

158 3 p. 631-639
artikel
27 Phase II study of axalimogene filolisbac (ADXS-HPV) for platinum-refractory cervical carcinoma: An NRG oncology/gynecologic oncology group study Huh, Warner K.

158 3 p. 562-569
artikel
28 Phase II study of pembrolizumab efficacy and safety in women with recurrent small cell neuroendocrine carcinoma of the lower genital tract Frumovitz, Michael

158 3 p. 570-575
artikel
29 Physical activity and exercise in women with ovarian cancer: A systematic review Jones, Tamara L.

158 3 p. 803-811
artikel
30 PIK3CA mutation and CNV status and post-chemoradiotherapy survival in patients with cervical cancer Martell, Kevin

158 3 p. 776-784
artikel
31 Principles of ethics and critical communication during the COVID-19 pandemic Shalowitz, David I.

158 3 p. 526-530
artikel
32 Prospective cohort study of metabolic syndrome and endometrial cancer survival Kokts-Porietis, Renée L.

158 3 p. 727-733
artikel
33 Risk of second primary cancers among survivors of gynecological cancers Adjei Boakye, Eric

158 3 p. 719-726
artikel
34 Role of molecular biomarker human papilloma virus (HPV) E6 oncoprotein in cervical cancer screening Ara, Rifat

158 3 p. 590-596
artikel
35 Small cell carcinoma of the ovary hypercalcemic type (SCCOHT): Comprehensive management of a newly diagnosed young adult Pressey, Joseph G.

158 3 p. 538-546
artikel
36 Social needs in gynecologic oncology: A Society of Gynecologic Oncology (SGO) clinical practice statement Esselen, K.

158 3 p. 521-525
artikel
37 Tamrintamab pamozirine (SC-003) in patients with platinum-resistant/refractory ovarian cancer: Findings of a phase 1 study Hamilton, Erika

158 3 p. 640-645
artikel
38 The role of neoadjuvant chemotherapy in the management of low-grade serous carcinoma of the ovary and peritoneum: Further evidence of relative chemoresistance Cobb, Lauren P.

158 3 p. 653-658
artikel
39 Time trends in the incidence and survival of vaginal squamous cell carcinoma and high-grade vaginal intraepithelial neoplasia in Denmark – A nationwide population-based study Bertoli, Hanna Kristina

158 3 p. 734-739
artikel
40 Transcriptomic and immunohistochemical approaches identify HLA-G as a predictive biomarker of gestational choriocarcinoma resistance to monochemotherapy Bolze, Pierre-Adrien

158 3 p. 785-793
artikel
41 Tumor-free margins and local recurrence in squamous cell carcinoma of the vulva Yang, Jie

158 3 p. 555-561
artikel
42 Value of endocervical curettage in follow-up for patients with cervical intraepithelial neoplasia stage 2+ after loop electrosurgical excision Cao, Dan

158 3 p. 584-589
artikel
43 Year 1: Experiences of a tertiary cancer centre following implementation of reflex BRCA1 and BRCA2 tumor testing for all high-grade serous ovarian cancers in a universal healthcare system McCuaig, Jeanna M.

158 3 p. 747-753
artikel
                             43 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland